|
TDRD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.45900000361843E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.95839999667302E-08 |
| Normal-vs-Stage2 |
8.388300E-04 |
| Normal-vs-Stage3 |
1.170110E-02 |
| Normal-vs-Stage4 |
1.329940E-02 |
| Stage1-vs-Stage2 |
3.246400E-01 |
| Stage1-vs-Stage3 |
6.851400E-01 |
| Stage1-vs-Stage4 |
3.942400E-01 |
| Stage2-vs-Stage3 |
3.054000E-01 |
| Stage2-vs-Stage4 |
8.742800E-01 |
| Stage3-vs-Stage4 |
3.255000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.21940002329302E-09 |
| Normal-vs-AfricanAmerican |
4.117200E-01 |
| Normal-vs-Asian |
1.412420E-01 |
| Caucasian-vs-AfricanAmerican |
2.483400E-03 |
| Caucasian-vs-Asian |
7.611600E-01 |
| AfricanAmerican-vs-Asian |
2.949800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.43479999992202E-07 |
| Normal-vs-Female |
4.33330000004783E-06 |
| Male-vs-Female |
1.165020E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.574400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.54750000003201E-06 |
| Normal-vs-Age(61-80Yrs) |
6.40220000014402E-07 |
| Normal-vs-Age(81-100Yrs) |
7.293000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.439400E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.939300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.560400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.097000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.498300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.758000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.043620E-02 |
| Normal-vs-Grade 2 |
1.48669965227555E-10 |
| Normal-vs-Grade 3 |
1.218940E-04 |
| Normal-vs-Grade 4 |
2.280200E-01 |
| Grade 1-vs-Grade 2 |
8.302000E-01 |
| Grade 1-vs-Grade 3 |
7.540200E-01 |
| Grade 1-vs-Grade 4 |
2.176000E-01 |
| Grade 2-vs-Grade 3 |
9.157800E-01 |
| Grade 2-vs-Grade 4 |
1.690000E-01 |
| Grade 3-vs-Grade 4 |
2.499800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.47326595367758E-13 |
| Normal-vs-ccB subtype |
1.840110E-02 |
| ccA subtype-vs-ccB subtype |
1.804080E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42449999999783E-05 |
| Normal-vs-N1 |
2.553200E-01 |
| N0-vs-N1 |
1.761970E-03 |
|
|
